Brief: IRLAB Q1 Operating Loss Widens To SEK 29.0 Mln

IRLAB Therapeutics AB

11/05/2022 06:50

May 11 (Reuters) - IRLAB Therapeutics AB  IRLABa.ST :
    * Q1 NET SALES SEK 9,0 MILLION VERSUS SEK 0 MILLION YEAR AGO
    * Q1 OPERATING LOSS SEK 29,0 MILLION VERSUS LOSS SEK 20.0
MILLION
YEAR AGO

Source text for Eikon:  ID:nMFN2Z4zb4 
Further company coverage:  IRLABa.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))